Terkko Navigator / Journal of Child and Adolescent Psychopharmacology

From the Editor-in-Chief's Desk

Maladaptive Aggression: With a Focus on Impulsive Aggression in Children and Adolescents

A Novel Assessment Tool for Impulsive Aggression in Children with Attention-Deficit/Hyperactivity Disorder

Application of the Impulsive Aggression Diary in Adolescents with Attention-Deficit/Hyperactivity Disorder

Clinical-Serological Characterization and Treatment Outcome of a Large Cohort of Italian Children with Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute Neuropsychiatric Syndrome

Immune-Related Comorbidities in Childhood-Onset Obsessive Compulsive Disorder: Lifetime Prevalence in the Obsessive Compulsive Disorder Collaborative Genetics Association Study

Establishing a Pediatric Acute-Onset Neuropsychiatric Syndrome Clinic: Baseline Clinical Features of the Pediatric Acute-Onset Neuropsychiatric Syndrome Cohort at Karolinska Institutet

Patient Satisfaction and Treatments Offered to Swedish Patients with Suspected Pediatric Acute-Onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections

Amantadine for Treatment of Disruptive Mood Dysregulation Disorder Symptoms

Infections, Antibiotics, and Mental Health Deteriorations

Raynaud's Phenomenon Related with Atomoxetine Treatment in a Child with Autism and Attention-Deficit/Hyperactivity Disorder

Severe Hypotension in an Adolescent After a Melatonin Overdose

Treatment Patterns, Health Care Resource Utilization, and Health Care Cost Associated with Atypical Antipsychotics or Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in Quebec, Canada

Probiotics for Gastrointestinal Symptoms and Quality of Life in Autism: A Placebo-Controlled Pilot Trial

A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Sett

The Impact of Placebo Response Rates on Clinical Trial Outcome: A Systematic Review and Meta-Analysis of Antidepressants in Children and Adolescents with Major Depressive Disorder

The Effect of Vitamin D Supplementation on Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Population-Based Epidemiology of Pediatric Patients with Treated Tic Disorders from Real-World Evidence in Korea

The Pharmacoepidemiology of Psychotropic Medication Use in Canadian Children from 2012 to 2016

Mineral-Vitamin Treatment Associated with Remission in Attention-Deficit/Hyperactivity Disorder Symptoms and Related Problems: 1-Year Naturalistic Outcomes of a 10-Week Randomized Placebo-Controlled Trial

The Correlation Between the Severity of Premonitory Urges and Tic Symptoms: A Meta-Analysis

Oral Contraceptives Reduced Pica Behavior in a Female with Autism Spectrum Disorder

Probable Galactorrhea Associated with Sequential Trials of Escitalopram and Duloxetine in an Adolescent Female

Naltrexone Reduces Binge Eating and Purging in Adolescents in an Eating Disorder Program

Selective Serotonin Reuptake Inhibitor Monotherapy for Anxiety Disorders in Children and Adolescents with Autism Spectrum Disorder: A Chart Review

An Open-Label, Multicenter, Single-Dose Pharmacokinetic Study of a Novel Amphetamine Extended-Release Orally Disintegrating Tablet in Preschool-Aged Children

Management of Depression in Adolescents in Japan

The Differential Impact of Social Media Use on Middle and High School Students: A Retrospective Study

Youth Growing Up in Families Experiencing Parental Substance Use Disorders and Homelessness: A High-Risk Population

Re:“Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial” by Findling et al.; (J Child Adolesc Psychopharmacol 2019;29:80–89)

Correction to“The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder across Home and School”

Youth Substance Use: Introduction to the Journal of Child and Adolescent Psychopharmacology Special Issue

A Transgenerational Perspective on Prevention and Treatment of Adolescent Substance Use Disorders

Developmental Consequences of Prenatal Substance Use in Children and Adolescents

Risk Factors for Drug Overdose in Young People: A Systematic Review of the Literature

Structural and Functional Neural Targets of Addiction Treatment in Adolescents and Young Adults: A Systematic Review and Meta-Analysis

Frontostriatal Resting State Functional Connectivity in Resilient and Non-Resilient Adolescents with a Family History of Alcohol Use Disorder

Reward Processing in Drug-Naive Youth with Various Levels of Risk for Substance Use Disorders: A Pilot Study

Threat Responsiveness as a Function of Cannabis and Alcohol Use Disorder Severity

Saliva DNA Methylation Detects Nascent Smoking in Adolescents

Electronic Vapor Product Usage and Substance Use Risk Behaviors Among U.S. High School Students

Associations Between School-Based Substance Use Treatment and Academic Outcomes

Pharmacological Treatment of Youth Substance Use Disorders

Correction to: Adjunctive Sleep Medications and Depression Outcome in the Treatment of Serotonin-Selective Reuptake Inhibitor Resistant Depression in Adolescents Study by Shamseddeen W, Clarke G, Keller MB, Wagner KD, Birmaher B, Emslie GJ, Ryan N, A

Correction to: Out of the Black Box: Treatment of Resistant Depression in Adolescents and the Antidepressant Controversy by Wagner KD, Asarnow JR, Vitiello B, Clarke G, Keller M, Emslie GJ, Ryan N, Porta G, Iyengar S, Ritz L, Zelanzny J, Onorato M, a

From the Editor-in-Chief's Desk

A Review of Factors Influencing the Three Phases of Medication Adherence in People with Attention-Deficit/Hyperactivity Disorder

Influence of Psychopharmacotherapy on the Quality of Life of Children with Attention-Deficit/Hyperactivity Disorder

Methylphenidate Treatment Initiated During Childhood Is Continued in Adulthood in Half of the Study Population

From the Editor-in-Chief's Desk